Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 7, p. 607, doi. 10.1007/s40261-019-00793-6
- By:
- Publication type:
- Article